EW News and Press, Edwards Lifesciences Corporation From 05/25/21

The medtech industry could be in the early stages "of another multi-year period out outperformance," according to a new analysis from Barclays.The firm has outlined 8 reasons why it is bullish on the industry: 1) robust innovation; last year's cancelled procedures are likely to return; 3) new...

Influential #investors can create defining moments in a stock's price, by simply making large #buyandsell decisions, and Edwards Lifesciences (NYSE: EW) is no exception.  Pivot points in a chart pattern are often created by these events, and as we have learned this does not req...

Real-world data shows that patients with bicuspid aortic stenosis treated with Edwards Lifesciences' (EW) SAPIEN 3 Ultra Transcatheter Aortic Valve Replacement ("TAVR") had low risk of death and stroke one year following surgery.There were not significant differences in primary outcomes betwe...

Clinical Data Updates On Edwards' Transcatheter Mitral, Tricuspid Programs Presented At EuroPCR PR Newswire IRVINE, Calif. , May 18, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical results from the company's transcatheter mitral...

Real-World Data Confirm Excellent Results For Bicuspid Patients Treated With Edwards SAPIEN 3 TAVR At 1 year, outcomes similar to overall cohort of patients PR Newswire IRVINE, Calif. , May 18, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today a...

#Investors often shrug off the impact of #stimulus but when fabricated demand comes into the #stockmarket everything is affected, even Edwards Lifesciences (NYSE: EW) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multiple exp...

Often, the action in a #stock is based on #investor perceptions, but it can be a circular event.  Not only is the #priceaction representative of perception, but it can influence perception too.  In the case of Edwards Lifesciences (NYSE: EW) we can see this in the charts. ...

When the market is in a phase of rich valuation, it is tempting to broadly identify the market for these stocks as “overvalued”. Making the distinction between stocks deserving high valuations and those that are overvalued is key, particularly in the current market. ...

Fisher’s 13F portfolio value increased from ~$133.5B to ~$142B in Q1 2021. They increased Walt Disney and Eli Lilly while trimming Taiwan Semi, JD.com, and Pinduoduo. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ke...

Stocks experienced a bit of a rollercoaster this week, starting off with some selling on Monday and Tuesday before rallying on Wednesday and into Thursday morning. That ended with news of President Biden's "American Family Plan," to be funded mainly by increasing the capital gains tax and the...